FWM
GNOM icon

Focused Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Focused Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18
Closed -$911 – 1092
2022
Q4 		$911 Buy
+18
New +$928 ﹤0.01% 880

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Focused Wealth Management's GNOM Position: Q1 2023 in Review

Focused Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2023, closing a stake of 18 shares — an estimated $911 sold.

Focused Wealth Management first reported a position in GNOM in Q4 2022 and held it in 1 quarter. The position peaked at $911 in Q4 2022. 63 funds tracked by Wall St. Rank hold GNOM as of Q1 2023.

  • Focused Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Focused Wealth Management sold 18 Global X Genomics & Biotechnology ETF shares in Q1 2023, an estimated $911.
  • Focused Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2022 and held it in 1 quarter.
  • Focused Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $911 in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2023.

Based on Focused Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.